Variation of luteinizing hormone and androgens in oligomenorrhoea and its implications for the study of polycystic ovary syndrome

Human Reproduction

Volumn 14, Issue 7, 1999, Pages 1684-1689

  Van Hooff, M H A ^a   Van Der Meer, M ^a   Lambalk, C B ^a   Schoemaker, J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Androgens; LH; Oligomenorrhoea; PCOS; Specific oligomenorrhoeic phase

Indexed keywords

ANDROGEN; ESTRADIOL; GONADOTROPIN; LUTEINIZING HORMONE;

ADULT; AMENORRHEA; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; OVULATION;

EID: 0032772298     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.7.1684     Document Type: Article

References (27)

1. Adams, J., Poison, D.W. and Franks, S. (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br. Med. J. Clin. Res. Ed., 293, 355-359.
2. Anonymous ( 1995) Diagnostic classification, basic diagnostic data collection. Recommendations by the Committee of the British Fertility Society, February 1995.
3. Anttila, L., Koskinen, P., Kaihola, H.L. et al. (1992) Serum androgen and gonadotrophin concentrations decline after progestogen-induced withdrawal bleeding in oligomenorrhoeic women with or without polycystic ovaries. Fertil. Steril., 58, 697-702.
4. Baien, A.H., Conway, G.S., Kaltsas, G. et al. (1995) Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum. Reprod., 10,2107-2111.
5. Blankstein, J., Rabinovici, J., Goldenberg, M. et al. (1987) Changing pituitary reactivity to follicle-stimulating hormone and luteinizing hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with polycystic ovarian disease. J. Clin. Endocrinol. Metab., 65,1164-1167.
6. Buckler, H.M., Phillips, S.E., Cameron, I.T. et al. (1988) Vaginal progesterone administration before ovulation induction with exogenous gonadotrophins in polycystic ovarian syndrome. J. Clin. Endocrinol. Metab., 67, 300-302.
7. Clayton, R.N., Ogden, V., Hodgkinson, J. et al. (1992) How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin. Endocrinol. Oxf., 37, 127-134.
8. Conway, G.S., Honour, J.W. and Jacobs, H.S. (1989) Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin. Endocrinol. Oxf., 30, 459-470.
9. Eden, J.A. (1988) Which is the best test to detect the polycystic ovary? Aust. N. Z J. Obstet. Gynaecol, 28, 221-224.
10. ESHRE Capri Workshop Group (1995). Anovulatory infertility. Hum. Reprod., 10, 1549-1553.
11. Franks, S. (1989) Polycystic ovary syndrome: a changing perspective. Clin. Endocrinol. Otf., 31, 87-120.
12. Franks, S. (1995) Polycystic ovary syndrome. N. Engl. J. Med., 333, 853-861.
13. Goldenberg, R.L., Grodin, J.M.,-Vaitukaitis, J.L. et al. (1973) Withdrawal bleeding and luteinizing hormone secretion following progesterone in women with amenorrhoea. Am. J. Obstet. Gynecol, 115, 193-195.
14. Homburg, R., Weissglas, L. and Goldman, J. (1988) Improved treatment for anovulation in polycystic ovarian disease utilizing the effect of progesterone on the inappropriate gonadotrophin release and clomiphene response. Hum. Reprod., 3, 285-288.
15. Hull, M.G.R. (1989) Polycystic ovarian disease: clinical aspects and prevalence. Res. Clin. Fonnns, 11, 21-33.
16. Koskinen, P., Penttilä, T., Anttila, L. et al (1996) Optimal use of hormone determinations in the biochemical diagnosis of the polycystic ovary syndrome. Fertil. Steril., 65, 517-522.
17. Lenton, E.A., Landgren, B.M. and Sexton, L. (1984) Normal variation in the length of the luteal phase of the menstrual cycle: identification of the short luteal phase. Br. J. Obstet. Gynaecol., 91, 685-689.
18. Minakami, H., Abe, N., Izumi, A. et al. (1988) Serum luteinizing hormone profile during the menstrual cycle in polycystic ovarian syndrome. Fertil. Steril, 50, 990-992.
19. Molloy, B.C., El Sheikh, M.A., Chapman, C. et al (1984) Pathological mechanisms in polycystic ovary syndrome: modulation of LH pulsatility by progesterone. Br. J. Obstet. Gynaecol, 91, 457-465.
20. Morales, A.J., Laughin, G.A., Bützow, T. et al (1996) Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J. Clin. Endocrinol. Metab., 81, 2854-2864.
21. Petsos, P., Ratcliffe, W.A. and Anderson, D.C. (1986) Effects of medroxyprogesterone acetate in women with polycystic ovary syndrome. Clin. Endocrinol. Ox}., 25, 651-660.
22. Prelevic, G.M., Würzburger, M.I. and Balint Peric, L. (1990) LH pulsatility and response to a single s.c. injection of buserelin in polycystic ovary syndrome. Gynecol. Endocrinol, 4, 1-13.
23. Robinson, S., Rodin, D.A., Deacon, A. et al. (1992) Which hormone tests for the diagnosis of polycystic ovary syndrome? Br. J. Obstet. Gynaecol, 99, 232-238.
24. van Santbrink, J.P., Hop, W.C. and Fauser, B.C. (1997) Classification of normogonadotrophic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertil. Steril., 67, 452-458.
25. Shoham, Z., Jacobs, H.S. and Insler, V. (1993) Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertil. Steril., 59, 1153-1161.
26. Taylor, A.E., McCourt, B., Martin, K.A. et al. (I997) Determinants of abnormal gonadotrophin secretion in clinically defined women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 82, 2248-2256.
27. World Health Organization (1993) WHO manual for the standardized investigation and diagnosis of the infertile couple. Cambridge University Press, Cambridge.